Lv3
328 积分 2022-11-28 加入
Journey of PROTAC: From Bench to Clinical Trial and Beyond
2天前
已完结
PROTAC targeted protein degraders: the past is prologue
12天前
已完结
Progress in the controllability technology of PROTAC
12天前
已完结
Advances with the discovery and development of novel sigma 1 receptor antagonists for the management of pain
14天前
已完结
Discovery, synthesis and biological evaluation of novel isoquinoline derivatives as potent indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase dual inhibitors
15天前
已完结
Design, synthesis, and evaluation of novel quindoline derivatives with fork-shaped side chains as RNA G-quadruplex stabilizers for repressing oncogene NRAS translation
15天前
已完结
Synthesis and Evaluation of a Novel c-Met-Targeting Cyclic Peptide as a Potential Diagnostic Agent for Colorectal Cancer
15天前
已完结
Pharmacological modulation of Sigma-1 receptor ameliorates pathological neuroinflammation in rats with diabetic neuropathic pain via the AKT/GSK-3β/NF-κB pathway
17天前
已完结
Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents
26天前
已完结
Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease
27天前
已完结
皖公网安备34019202002308
